IPIX (Innovation Pharmaceuticals) PB Ratio: 0.15 (As of Jun. 25, 2026)

What is Innovation Pharmaceuticals PB Ratio?

Innovation Pharmaceuticals IPIX PB Ratio is 0.15 as of Jun. 25, 2026.

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-25), Innovation Pharmaceuticals's share price is $0.0003. Innovation Pharmaceuticals's Book Value per Share for the quarter that ended in Sep. 2023 was $0.00. Hence, Innovation Pharmaceuticals's PB Ratio of today is 0.15.

The historical rank and industry rank for Innovation Pharmaceuticals's PB Ratio or its related term are showing as below:

IPIX's PB Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.8
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio

Innovation Pharmaceuticals (OTCPK:IPIX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Innovation Pharmaceuticals PB Ratio Related Terms

Innovation Pharmaceuticals PB Ratio Historical Data

* Premium members only.

The historical data trend for Innovation Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovation Pharmaceuticals PB Ratio Chart

Innovation Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

PB Ratio

Get a 7-Day Free Trial

0.00

101.25

12.68

3.44

5.00

Innovation Pharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
PB Ratio	Get a 7-Day Free Trial															4.77	3.17	4.00	5.00	6.00

IPIX vs AXIM, RNAZ, APTX: PB Ratio Comparison

For the Biotechnology subindustry, Innovation Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Innovation Pharmaceuticals PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innovation Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Innovation Pharmaceuticals's PB Ratio falls into.

Save Embed

Innovation Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Innovation Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Sep. 2023)
	=	0.0003	/	0.002
	=	0.15

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Frequently Asked Questions Learn more about PB Ratio →

What does a PB Ratio of 0.15 mean?

Innovation Pharmaceuticals (IPIX) has a PB Ratio of 0.15 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Innovation Pharmaceuticals and its competitors.

Is Innovation Pharmaceuticals' PB Ratio too high?

Innovation Pharmaceuticals' current PB Ratio is 0.15. The Biotechnology industry median PB Ratio is 2.80. Innovation Pharmaceuticals' value of 0.15 is 94.6% below this industry median.

How does Innovation Pharmaceuticals' PB Ratio compare to AXIM and RNAZ?

Innovation Pharmaceuticals' PB Ratio of 0.15 can be compared against companies in the Biotechnology industry. The industry median PB Ratio is 2.80. Innovation Pharmaceuticals' value of 0.15 is 94.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good PB Ratio for a Biotechnology company?

The median PB Ratio among Biotechnology companies is 2.80, based on 1,233 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Innovation Pharmaceuticals's current PB Ratio of 0.15 is 94.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high PB Ratio mean?

A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Innovation Pharmaceuticals and its competitors. For the Biotechnology industry, the median PB Ratio is 2.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovation Pharmaceuticals's current PB Ratio is 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Innovation Pharmaceuticals stock overvalued right now?

Innovation Pharmaceuticals (IPIX) has a current PB Ratio of 0.15. The current PB Ratio is 0.15 and 94.6% below the Biotechnology industry median of 2.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is PB Ratio calculated?

PB Ratio is calculated from a company's financial statements. For Innovation Pharmaceuticals (IPIX), the current PB Ratio is 0.15 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovation Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies AXIM RNAZ APTX CPMV VRAX KPRX NEXI QRON ENDV ENVB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 301 Edgewater Place, Suite 100, Wakefield, MA, USA, 01880

Website http://www.ipharminc.com

Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, and inflammatory disease.